The patient, a 36-year old male with bipolar disorder maintained on lithium slow release tablets, was admitted with tremors and loss of coordination. His serum lithium level was reported as 1.4 mmol/L, above the recommended range of 0.4-1 mmol/L. The patient admits to taking his mother's arthritis medications for a migraine. NSAIDs can interact with lithium and increase toxicity risks. Management includes hydration, assessing renal function, providing lithium toxicity education, and consulting a doctor for any future illnesses to ensure proper treatment. Monitoring for side effects should begin 12 hours after each dose and continue every 3 months if no issues arise.
The patient, a 36-year old male with bipolar disorder maintained on lithium slow release tablets, was admitted with tremors and loss of coordination. His serum lithium level was reported as 1.4 mmol/L, above the recommended range of 0.4-1 mmol/L. The patient admits to taking his mother's arthritis medications for a migraine. NSAIDs can interact with lithium and increase toxicity risks. Management includes hydration, assessing renal function, providing lithium toxicity education, and consulting a doctor for any future illnesses to ensure proper treatment. Monitoring for side effects should begin 12 hours after each dose and continue every 3 months if no issues arise.
The patient, a 36-year old male with bipolar disorder maintained on lithium slow release tablets, was admitted with tremors and loss of coordination. His serum lithium level was reported as 1.4 mmol/L, above the recommended range of 0.4-1 mmol/L. The patient admits to taking his mother's arthritis medications for a migraine. NSAIDs can interact with lithium and increase toxicity risks. Management includes hydration, assessing renal function, providing lithium toxicity education, and consulting a doctor for any future illnesses to ensure proper treatment. Monitoring for side effects should begin 12 hours after each dose and continue every 3 months if no issues arise.
The patient, a 36-year old male with bipolar disorder maintained on lithium slow release tablets, was admitted with tremors and loss of coordination. His serum lithium level was reported as 1.4 mmol/L, above the recommended range of 0.4-1 mmol/L. The patient admits to taking his mother's arthritis medications for a migraine. NSAIDs can interact with lithium and increase toxicity risks. Management includes hydration, assessing renal function, providing lithium toxicity education, and consulting a doctor for any future illnesses to ensure proper treatment. Monitoring for side effects should begin 12 hours after each dose and continue every 3 months if no issues arise.
Nabillah BMM (1607062023) Sudin (1607062024) Arie Dwi Pratiwi (1607062025) Khairul Huda (1607062026) Venty Dewintasari (1607062027) Nova anggreni (1607062028) Kasus A 36 years-old male patient with a history of bipolar disorder controlled with lithium is admitted with coarse tremor and loss of co- ordination. The patient is maintained on lithium slow release tablets (priadel) 400 mg twice daily. A serum lithium level is reported as 1,4 mmol/L. Introduction TDM is the clinical practice of measuring spesific drugs at designated intervals to make maintan a counstan consentration in a patient bloodstream. ( An education guide) (menentukan interval dosis agar tercapai
kosentrasi yang konstant dalam darah)
Lithium Indikasi : terapi dan pencegahan penyakit mania, bipolar disorder, depresi kambuhan. Efek samping : Gangguan GI, Tremor,
kerusakan ginjal, polidipsi, leukositosis,
hiperparatiroid dan hiperkalsemia. Struktur : Contoh Produk Lithium recommended serum concentration range for lithium in the BNF Lithium salts have a narrow therapeutic/toxic ratio and should therefore not be prescribed unless facilities for monitoring serum-lithium concentrations are available. Samples should be taken12 hours after the dose to achieve a serum- lithium concentration of 0.4–1 mmol/litre (lower end of the range for maintenance therapy and elderly patients). A target serum-lithium concentration of 0.8–1 mmol/litre is recommended for acute episodes of mania, and for patients who have previously relapsed or have subsyndromal symptoms. Baselines test and monitoring interaksi List the posible explanation for this patient high lithium level and what question you will ask the patient
1. Terapi keracunan litium dengan hidrasi
menggunakan IV sodium chloride 0.9%. 2. Menggali informasi terkait riwayat penyakit pasien. 3. Cek fungsi ginjal 4. Memberikan konseling kepada pasien terkait gejala toksisitas litium, seperti tremor, ataxia, nistagmus, kerusakan ginjal, konvulsi/kejang, jika terjadi gejala tersebut segera kerumah sakit. The patient admits to borrowing some of his mother’s arthritis tablets for a migraine that had been bothering him for several days. Check the BNF appendix 1 and list the possible drugs the that interact with lithium that are also for symptoms relief of arhtiritis
Obat arthritis berupa golongan NSAID dapat
berinteraksi dengan litium sehingga dapat meningkatkan toksisitasnya, maka jika pasien mengalami keluhan migrain disarankan untuk memeriksakan kepada dokter supaya mendapat penanganan yang tepat. How should this patient be managed once the lithium toxicity has resolved. Untuk menghindari agar tidak terjadi toksisitas kembali, maka tugas apoteker memberikan konseling pemahaman obat litium kepada keluarga pasien. Khususnya konseling terhadap gejala toksisitas dari lithium. Agar kejadian tersebut tidak terulang, maka jika pasien mengalami gejala toksisitas, kekambuhan penyakit, dan ada penyakit lain disarankan untuk langsung konsultasi kepada dokter terkait terapi pengobatannya. Wisnu Kapan dilakukan monitoring terhadap efek
samping obat. Jawab Tepatnya dimulai sejak 12 jam setelah
mengkonsumsi obat jika tidak terdapat
masalah maka dilanjutkan dan dilakukan monitoring 3 bulan selanjutnya